GLOBAL LEADERSHIP SOLUTIONS
Designation | Company | Designation | Company |
CEO | Publicly-listed US Pharma | VP, Business Development | Japan Subsidiary, Generics Pharma |
CEO | Private Biopharmaceutical | Country Head, China | US Rx Pharma |
Regional Head, Asia | European Biopharmaceutical | Country Head, India | US Rx Pharma |
President | US Subsidiary, Generics Pharma | Regional Head, Middle East | US Rx Pharma |
DIA Head | Multi-national Pharma | CEO, Brazil | Private Generics Pharma |
COO, Canada | US Subsidary, Specialty Pharma | Regional Head, Latin America | US Rx Pharma |
VP, Clinical Development | European Pharma | VP, Europe | European Subsidiary, Generics Pharma |
CSO/President, R&D | Publicly-listed Generics Pharma | President, Europe | European Subsidiary, Specialty Pharma |
Regional Head, Asia | US Publicly-listed Chemicals | VP, Business Development | CRAMS |
VP, Commercial Operations | US Subsidary, Biopharma | GM, Operations/ Manufacturing | US Pharma |
VP, Regulatory Affairs | US Subsidiary, Generics Pharma | VP, Strategic Planning | US Publicly-listed Chemicals |
VP, Corporate Development | US Subsidiary, Specialty Pharma | EVP, Specialty | Indian Pharma |
VP, Quality | Publicly-Listed Indian Biopharma | President, Japan | Japanese Specialty Chemicals |
VP & GM | US Specialty Chemicals | CFO, Global | Global Pharma |
CEO | Hospital Chain | VP, Intermediates, USA | Private Pharma |
SVP, Process Development | Publicly-Listed Biopharma | VP, Clinical Development | Publicly-listed Pharma |
CEO, Japan | Japan Subsidiary Generics Pharma | Medical Director | Rx Pharma |
VP, Compliance | Global Pharma | VP, Biosimilars | US Pharma |
VP, Injectible Development | US Pharma | GM, Site Operations | Global Pharma |